A Review of Perspectives on the Use of Randomization in Phase II Oncology Trials (2019)
Attributed to:
MRC North West Hub for Trials Methodology Research
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/jnci/djz126
PubMed Identifier: 31218346
Publication URI: http://europepmc.org/abstract/MED/31218346
Type: Journal Article/Review
Parent Publication: JNCI: Journal of the National Cancer Institute
Issue: 12
ISSN: 0027-8874